| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 8.668 | 83.315 | 186.434 | 223.737 | 298.712 | 475.205 | 1.164.439 | 1.403.557 | 1.772.161 |
| Total Income - EUR | 0 | 8.668 | 83.316 | 186.436 | 223.742 | 328.760 | 475.220 | 1.164.468 | 1.424.435 | 1.773.973 |
| Total Expenses - EUR | 34 | 16.756 | 80.685 | 171.225 | 205.071 | 298.964 | 414.922 | 1.050.464 | 1.317.193 | 1.651.989 |
| Gross Profit/Loss - EUR | -34 | -8.088 | 2.632 | 15.211 | 18.672 | 29.796 | 60.298 | 114.004 | 107.242 | 121.984 |
| Net Profit/Loss - EUR | -34 | -8.179 | 1.757 | 13.275 | 16.356 | 26.809 | 56.406 | 105.766 | 92.676 | 107.354 |
| Employees | 1 | 1 | 3 | 4 | 3 | 3 | 6 | 13 | 16 | 20 |
Check the financial reports for the company - Quality Pharma Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 1.596 | 1.378 | 3.799 | 42.457 | 5.258 | 5.652 | 27.296 | 73.119 | 66.997 |
| Current Assets | 67 | 10.735 | 29.142 | 41.092 | 47.945 | 149.615 | 180.974 | 385.167 | 513.066 | 718.316 |
| Inventories | 0 | 5.388 | 14.098 | 17.368 | 16.309 | 43.549 | 114.495 | 132.970 | 228.779 | 277.485 |
| Receivables | 0 | 1.993 | 8.896 | 18.989 | 26.691 | 40.170 | 59.429 | 230.740 | 268.512 | 287.433 |
| Cash | 67 | 3.354 | 6.148 | 4.735 | 4.945 | 65.896 | 7.050 | 21.457 | 15.775 | 153.397 |
| Shareholders Funds | 34 | -8.146 | -6.251 | 7.139 | 23.358 | 26.900 | 56.479 | 105.939 | 92.752 | 107.622 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 34 | 20.477 | 36.771 | 37.751 | 67.044 | 127.973 | 130.147 | 306.524 | 493.433 | 677.691 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Quality Pharma Concept S.r.l.